These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 2616574

  • 1. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
    Marks PA, Michaeli J, Jackson J, Richon VM, Rifkind RA.
    Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574
    [Abstract] [Full Text] [Related]

  • 2. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
    Marks PA, Rifkind RA.
    Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
    [Abstract] [Full Text] [Related]

  • 3. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
    Marks PA, Ramsay R, Sheffery M, Rifkind RA.
    Prog Clin Biol Res; 1987 Jul; 251():253-68. PubMed ID: 3481077
    [Abstract] [Full Text] [Related]

  • 4. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
    Chen ZX.
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation.
    Richon VM, Ramsay RG, Rifkind RA, Marks PA.
    Oncogene; 1989 Feb; 4(2):165-73. PubMed ID: 2648254
    [Abstract] [Full Text] [Related]

  • 10. Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process.
    Chen Z, Banks J, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):471-5. PubMed ID: 6952199
    [Abstract] [Full Text] [Related]

  • 11. Characteristics of erythroleukemia cells selected for vincristine resistance that have accelerated inducer-mediated differentiation.
    Richon VM, Weich N, Leng L, Kiyokawa H, Ngo L, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1991 Mar 01; 88(5):1666-70. PubMed ID: 1672043
    [Abstract] [Full Text] [Related]

  • 12. Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division.
    Ramsay RG, Ikeda K, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1986 Sep 01; 83(18):6849-53. PubMed ID: 3462732
    [Abstract] [Full Text] [Related]

  • 13. Modulation of gene expression during terminal cell differentiation: murine erythroleukemia.
    Marks PA, Murate T, Kaneda T, Ravetch J, Rifkind RA.
    Symp Fundam Cancer Res; 1984 Sep 01; 37():327-40. PubMed ID: 6084863
    [Abstract] [Full Text] [Related]

  • 14. Modulation of gene expression during terminal cell differentiation.
    Marks PA, Sheffery M, Rifkind RA.
    Prog Clin Biol Res; 1985 Sep 01; 191():185-203. PubMed ID: 3901038
    [Abstract] [Full Text] [Related]

  • 15. Vincristine-resistant erythroleukemia cell line has marked increased sensitivity to hexamethylenebisacetamide-induced differentiation.
    Melloni E, Pontremoli S, Damiani G, Viotti P, Weich N, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1988 Jun 01; 85(11):3835-9. PubMed ID: 3163801
    [Abstract] [Full Text] [Related]

  • 16. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
    Corin RE, Haspel HC, Peretz AM, Sonenberg M, Rifkind RA.
    Cancer Res; 1986 Mar 01; 46(3):1136-41. PubMed ID: 3455880
    [Abstract] [Full Text] [Related]

  • 17. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M, Boss GR, Pascual FE, Pilz RB.
    Cell Growth Differ; 1995 Dec 01; 6(12):1559-66. PubMed ID: 9019161
    [Abstract] [Full Text] [Related]

  • 18. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
    Waxman S, Scher BM, Hellinger N, Scher W.
    Cancer Res; 1990 Jul 01; 50(13):3878-87. PubMed ID: 2354439
    [Abstract] [Full Text] [Related]

  • 19. A rise and fall in 1,2-diacylglycerol content signal hexamethylene bisacetamide-induced erythropoiesis.
    Michaeli J, Busquets X, Orlow I, Younes A, Colomer D, Marks PA, Rifkind RA, Kolesnick RN.
    J Biol Chem; 1992 Nov 25; 267(33):23463-6. PubMed ID: 1429688
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of protein kinase C isozymes and erythroleukemia cell differentiation.
    Melloni E, Pontremoli S, Viotti PL, Patrone M, Marks PA, Rifkind RA.
    J Biol Chem; 1989 Nov 05; 264(31):18414-8. PubMed ID: 2808382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.